Polymorphism’s MBOAT7 as Risk and MTARC1 as Protection for Liver Fibrosis in MASLD
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136406 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sofia Rocha und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Gastroenterologia e Hepatologia Tropical-LIM07, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo 05508-000, SP, B…. Hauptthemen laut MEDLINE: Liver Cirrhosis, Polymorphism, Single Nucleotide, Membrane Proteins, Acyltransferases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation (FAPESP), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brasil (CAPES).
Abstract (Originalsprache)
Previous large-scale genetic studies identified single-nucleotide polymorphisms (SNPs) of the membrane bound O-acyltransferase domain containing 7 (MBOAT7) and patatin-like phospholipase domain containing 3 (PNPLA3) genes as risk factors for metabolic dysfunction-associated steatotic liver disease (MASLD). However, this has not yet been investigated in Brazilian patients. In this study, we evaluated the association between the PNPLA3 variant rs738409 and MBOAT7 variant rs641738 and the risk of hepatic fibrosis or liver cirrhosis in MASLD etiology. In parallel, we also aimed to evaluate a protective SNP of the mitochondrial amidoxime-reducing component 1 (MTARC1) gene. We also evaluated TM6SF2 rs58542926, GCKR rs1260326 and rs780094, and HSD17B13 rs72613567 and they were not associated with liver fibrosis. The study was conducted at the Department of Gastroenterology and Nutrology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), and included 113 patients with liver fibrosis (F0–F1), 99 patients with significant liver fibrosis (F2–F4), and 90 controls. SNPs were genotyped by quantitative PCR, using TaqMan allelic discrimination assays. Overall, the PNPLA3 GG genotype was more frequent in F2–F4 (23%) and F0–F1 (22%) patients than in controls (9%; p = 0.02). The MBOAT7 TT genotype was significantly associated with fibrosis, with a prevalence of 23% in F2–F4 patients versus 10% in F0–F1 and 11% in controls (p = 0.01). This association was confirmed by regression analysis (OR = 5.01 95% CI: 1.86–13.49; p = 1.41 × 10−3). The protective MTARC1 AA genotypes were more frequent in controls (52%) when compared to patients with fibrosis (5% p = 2.76 × 10−20).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Gastroenterologia e Hepatologia Tropical-LIM07, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo 05508-000, SP, Brazil.
- Laboratório de Gastroenterologia Clínica e Experimental-LIM07, Departamento de Gastroenterologia, Hospital das Clínicas Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo 05403-000, SP, Brazil.
- Departamento de Patologia, LIM/03-Laboratório de Medicina Laboratorial, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo 05403-000, SP, Brazil.
- Departamento de Patologia-LIM01, Faculdade de Medicina da Universidade de São Paulo, São Paulo 05508-000, SP, Brazil.
- Hospital Israelita Albert Einstein, São Paulo 05652-900, SP, Brazil.
ORCID-Profile: Sofia Rocha, José Tadeu Stefano, Patricia Momoyo Youshimura Zitelli, Flavio F Alcantara, Raymundo S Azevedo, João Renato Rebello Pinho
Förderung
- São Paulo Research Foundation (FAPESP)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brasil (CAPES)
Zitieren
APA
Rocha, S., Oliveira, C. P., Stefano, J. T., Yokogawa, R. P., Gomes-Gouvea, M., Zitelli, P. M. Y., Silva-Etto, J. M. K., Martins, E. D., Pessoa, M. G., Alcantara, F. F., Azevedo, R. S., & Rebello Pinho, J. R. (2025). Polymorphism’s MBOAT7 as Risk and MTARC1 as Protection for Liver Fibrosis in MASLD. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136406
Vancouver
Rocha S, Oliveira CP, Stefano JT, Yokogawa RP, Gomes-Gouvea M, Zitelli PMY, et al. Polymorphism’s MBOAT7 as Risk and MTARC1 as Protection for Liver Fibrosis in MASLD. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136406
BibTeX
@article{Rocha2025,
author = {Rocha, Sofia and Oliveira, Claudia P and Stefano, José Tadeu and Yokogawa, Roberta P and Gomes-Gouvea, Michele and Zitelli, Patricia Momoyo Youshimura and Silva-Etto, Joyce Matie Kinoshita and Martins, Eduarda Donegá and Pessoa, Mario G and Alcantara, Flavio F and Azevedo, Raymundo S and Rebello Pinho, João Renato},
title = {Polymorphism’s MBOAT7 as Risk and MTARC1 as Protection for Liver Fibrosis in MASLD},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136406}
}
EUVIMED